CAR-T Cells & Oncolytic Viruses against Solid Tumors

سال انتشار: 1401
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 93

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

MEDISM23_325

تاریخ نمایه سازی: 16 مهر 1401

چکیده مقاله:

Background and Aim : Adoptive transfer of chimeric antigen receptor (CAR) modified T cellshas resulted in unprecedented rates of sustained complete response in leukemia and lymphomapatients.Methods : However, despite significant results in patients with hematological malignancies,CART cells display limited effect on solid cancers. New approaches must simultaneouslyovercome many of the challenges faced by CART cells in solid tumours, containing theimmunosuppressive tumor microenvironment and the heterogeneity of antigen expression.Results : Oncolytic viruses are lytic and immunogenic anti-cancer agents that have the potentialfor synergism with CAR-T cells to treat of solid tumor.Conclusion : In addition, viruses can be modified to deliver therapeutic transgenes selectively tothe tumor microenvironment, which can enhance the effective functions of tumor-specific T cells.

کلیدواژه ها:

نویسندگان

Piruz Shadbash

Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Seyed Reza Mohebbi

Research Center for Gastroenterology and Liver Diseases, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Seyed Masoud Hosseini

Department of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran